UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 4, 2023
Accession Number:
0001640455-23-000096
Submission Type:
POS AM
CIK:
0001640455
Company Name:
Jounce Therapeutics, Inc.
File Number:
333-223518